An over-the-counter medication sold today as Zantac 360 by Sanofi has a different active ingredient from the withdrawn versions of Zantac and has not raised questions about a cancer link.
In 2020, US regulators pulled Zantac off shelves due to fears that a key ingredient, ranitidine ... A drug under the name of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback